DE

DE Stock -- What's In It For Investors?

It's been a great afternoon session for Deere & investors, who saw their shares rise 2.1% to a price of $446.65 per share. At these higher prices, is the company still fairly valued? If you are thinking about investing, make sure to check the company's fundamentals before making a decision.

a Very Low P/E Ratio but Its Shares Are Expensive:

Deere & Company engages in the manufacture and distribution of various equipment worldwide. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 25.42 and an average price to book (P/B) ratio of 3.2. In contrast, Deere & has a trailing 12 month P/E ratio of 17.4 and a P/B ratio of 5.3.

Deere & has moved 23.3% over the last year compared to 31.2% for the S&P 500 — a difference of -7.9%. Deere & has a 52 week high of $447.5 and a 52 week low of $340.2.

Growing Revenues and Generally Positive Cash Flows:

2018 2019 2020 2021 2022 2023
Revenue (M) $37,358 $39,258 $35,540 $44,024 $52,577 $61,251
Operating Margins 12% 11% 12% 18% 18% 21%
Net Margins 6% 8% 8% 14% 14% 17%
Net Income (M) $2,368 $3,253 $2,751 $5,963 $7,131 $10,166
Net Interest Expense (M) $1,204 $1,466 $1,247 $993 $1,062 $2,453
Depreciation & Amort. (M) $754 $779 $800 $2,050 $1,895 $2,004
Diluted Shares (M) 327 321 317 314 306 294
Earnings Per Share $7.24 $10.15 $8.69 $18.99 $23.28 $34.63
EPS Growth n/a 40.19% -14.38% 118.53% 22.59% 48.75%
Avg. Price $138.75 $152.96 $179.64 $341.71 $366.37 $446.65
P/E Ratio 18.9 14.88 20.48 17.85 15.64 12.83
Free Cash Flow (M) $926 $2,292 $6,663 $6,878 $3,565 $7,091
CAPEX (M) $896 $1,120 $820 $848 $1,134 $1,498

Deere & has growing revenues and increasing reinvestment in the business and strong operating margins with a positive growth rate. Additionally, the company's financial statements display exceptional EPS growth and generally positive cash flows.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS